What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Seattle Genetics to acquire Cascadian Therapeutics for $614m to bolster oncology portfolio Seattle Genetics, a leader in oncology biotechnology, has announced the acquisition of Cascadian Therapeutics for approximately $614 million,… bySrinathFebruary 3, 2018
